Immune Therapy Offers Rare Hope for Ovarian Cancer

An experimental treatment that trains a woman's immune system to target her own ovarian tumors has helped at least 20 women live longer and might point to a way to manage one of the most deadly cancers out there. Researchers told a meeting Saturday that even older cancer drugs might help women live longer with ovarian cancer. Avastin, used for a range of cancers, added a valuable five months on average to women's lives without as many side effects, including deadly stomach bleeding, as was feared. Ovarian cancer's been in the headlines because actor and director Angelina Jolie announced she had her ovaries removed surgically to avert her very high risk of ovarian cancer. Jolie, who inherited DNA mutations that put her at high risk, also had both breasts removed two years ago.